These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 6346500

  • 1. Ursodeoxycholic acid treatment of gallstones.
    Thistle JL.
    Semin Liver Dis; 1983 May; 3(2):146-56. PubMed ID: 6346500
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K.
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [Abstract] [Full Text] [Related]

  • 5. Current status of chenodeoxycholic acid (chenodiol) therapy of cholesterol gallstones.
    Zak RA, Marks JW, Schoenfield LJ.
    Semin Liver Dis; 1983 May; 3(2):132-45. PubMed ID: 6408740
    [No Abstract] [Full Text] [Related]

  • 6. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M, Panveliwalla D, Pertsemlidis D.
    Mt Sinai J Med; 1983 May; 50(3):240-4. PubMed ID: 6604868
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ursodeoxycholic acid for adjuvant therapy with extracorporeal shock wave lithotripsy of gallstones.
    Fromm H.
    J Clin Gastroenterol; 1988 May; 10 Suppl 2():S18-21. PubMed ID: 3062080
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Does drug-induced litholysis still have a place in treatment of gallstones?].
    Swobodnik W.
    Ther Umsch; 1993 Aug; 50(8):564-9. PubMed ID: 8211857
    [Abstract] [Full Text] [Related]

  • 11. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF, Thistle JL.
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [Abstract] [Full Text] [Related]

  • 12. Gallstone dissolution and the cholesterol--bile acid--lipoprotein axis. Propitious effects of ursodeoxycholic acid.
    Fromm H.
    Gastroenterology; 1984 Jul; 87(1):229-33. PubMed ID: 6724267
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ursodeoxycholic acid vs. chenodeoxycholic acid as cholesterol gallstone-dissolving agents: a comparative randomized study.
    Roda E, Bazzoli F, Labate AM, Mazzella G, Roda A, Sama C, Festi D, Aldini R, Taroni F, Barbara L.
    Hepatology; 1982 Jul; 2(6):804-10. PubMed ID: 7141392
    [Abstract] [Full Text] [Related]

  • 16. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A, Raedsch R, Czygan P, Götz R, Männer C, Walker S, Kommerell B.
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Cholelitholysis--gallbladder sediments and pigment stones].
    Wolpers C, Wosiewitz U.
    Leber Magen Darm; 1985 Mar; 15(2):64-70. PubMed ID: 3990499
    [Abstract] [Full Text] [Related]

  • 19. Gall stone dissolving agents.
    Bouchier IA.
    Br Med J (Clin Res Ed); 1983 Mar 05; 286(6367):778-80. PubMed ID: 6402249
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.